Hepion Pharmaceuticals Inc. buy BiotechBee
Start price
10.01.23
/
50%
€12.12
Target price
31.03.25
€30.00
Performance (%)
-7.13%
End price
05.05.23
€11.26
Summary
This prediction ended on 05.05.23 with a price of €11.26. With a performance of -7.13%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Hepion Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | -1.611% | 3.135% | 15.880% |
iShares Nasdaq 100 | -0.500% | 0.775% | 20.054% |
iShares Nikkei 225® | -1.483% | 4.610% | 11.154% |
iShares S&P 500 | -0.501% | 1.914% | 21.016% |
According to BiotechBee what are the pros and cons of Hepion Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Hepion Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 1,5
In the thread Trading Hepion Pharmaceuticals Inc.
Buy beendet